In this episode, Dr. Colleen Cutcliffe explores antibiotic effects on gut microbiome, Akkermansia, GLP-1 stimulation, and implications of gut-brain communication on neurological disorders like Parkinson's and Alzheimer's.

They dive into:

1. The evolution of antibiotics

2. The recent discovery of the keystone probiotic strain Akkermansia

3. Akkermansia’s benefits

4. How neurons in the gut communicate with the brain

Dr. Colleen Cutcliffe, Cofounder and CEO of Pendulum Therapeutics, is leading a dedicated team in their pursuit of groundbreaking and transformative solutions for gut health-related ailments, showcasing a remarkable passion for improving people's lives through revolutionary, safe, and effective microbiome interventions.

Labs Mentioned: